| Literature DB >> 36187629 |
Xiao-Jia Sun1, Guo-Heng Zhang1, Chang-Mei Guo1, Zi-Yi Zhou1, Ya-Li Niu1, Ling Wang2, Guo-Rui Dou1.
Abstract
Introduction: Diabetes mellitus (DM) and diabetic retinopathy (DR) increase the global burden. Since their pathogenesis is complex, it is necessary to use the biopsychosocial model to discover the most effective strategies. The study is aimed to investigate the psycho-behavioral factors of DR and confirm the discrepancies from previous studies. Research design and methods: The study comprised seven cycles of cross-sectional data of the National Health and Nutrition Examination Survey (NHANES) from 2005-2006 to 2017-2018. Samples of DM were selected from this complex multi-stage probability sample and divided into the non-DR and DR groups, where 4,426 samples represented 18,990,825 individuals after weighting. This study comprehensively explored the biological, social, and psychological risk factors of DR, among which the biological factors included blood pressure, blood routine, HbA1c%, blood glucose, the duration of DM, family history, comorbidities, and treatment methods. Social aspects include gender, education, income, insurance, smoking, drinking, sleep habits, and recreational activities. The Patient Health Questionnaire-9 (PHQ-9) was used to assess the psychological state. Taylor series regression was used to examine the connection between factors and DR.Entities:
Keywords: NHANES; depression; diabetic retinopathy; recreational activity; sleep duration
Mesh:
Substances:
Year: 2022 PMID: 36187629 PMCID: PMC9521717 DOI: 10.3389/fpubh.2022.966714
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Figure 1Flow diagram of the study population's inclusion and exclusion criteria. 2005–2018 National Health and Nutrition Examination Survey (NHANES).
Baseline characteristics of diabetes in NHANES.
|
|
|
|
|
|
|---|---|---|---|---|
|
|
|
| ||
| N | 4426 | 3491 | 935 | |
| Frequency (weighted) | 18990825 | 14857122 | 4133703 | |
|
| ||||
| Age (years) | 60.7 ± 0.7 | 60.6 ± 0.8 | 61.0 ± 1.3 | 0.5790 |
| Gender (male, %) | 50.3 (48.0–52.6) | 48.8 (46.2–51.5) | 55.5 (50.8–60.3) | 0.0174 |
| 0.0322 | ||||
| <1.3 (low) | 30.8 (28.2–33.4) | 29.4 (26.8–32.1) | 35.7 (30.3–41.1) | |
| 1.3–4.9 (medium) | 47.1 (44.8–49.5) | 48.5 (46.1–50.9) | 42.2 (36.6–47.7) | |
| 5 (high) | 13.0 (11.2–14.9) | 13.4 (11.4–15.4) | 11.7 (8.3–15.0) | |
| 0.0019 | ||||
| 0 | 49.4 (46.9–51.9) | 47.3 (44.5–50.1) | 56.9 (52.1–61.7) | |
| 1 | 47.5 (45.1–49.9) | 49.4 (46.7–52.1) | 40.7 (36.0–45.3) | |
| 2 | 3.1 (2.2–4.0) | 3.3 (2.3–4.3) | 2.4 (0.8–4.0) | |
|
| ||||
| SBP (mmHg) | 131.1 ± 0.91 | 130.6 ± 1.0 | 133.2 ± 2.1 | 0.0212 |
| Lymphocyte count (×109/L) | 2.3 ± 0.1 | 2.3 ± 0.1 | 2.1 ± 0.1 | 0.0004 |
| Fasting glucose (mg/dL) | 157.7 ± 3.0 | 153.9 ± 3.3 | 171.7 ± 6.8 | <0.0001 |
| HbA1c (%) | 7.4 ± 0.1 | 7.3 ± 0.1 | 7.8 ± 0.2 | <0.0001 |
| ACR (mg/g) | 160.9 ± 25.0 | 118.7 ± 19.3 | 312.3 ± 87.0 | <0.0001 |
| Family history (yes %) | 69.7 (67.5–71.9) | 68.2 (65.8–70.6) | 75.0 (70.5–79.5) | 0.0313 |
| Duration of diabetes (years) | 11.5 ± 0.46 | 10.3 ± 0.5 | 15.7 ± 1.1 | <0.0001 |
| Frequency of self–monitoring blood | 1.9 ± 0.09 | 1.8 ± 0.1 | 2.2 ± 0.2 | 0.0062 |
|
| <0.0001 | |||
| Pills only | 56.4 (53.9–58.8) | 60.5 (57.9–63.2) | 41.4 (36.3–46.5) | |
| Insulin only | 13.4 (12.6–15.4) | 10.0 (8.4 −11.7) | 25.3 (21.2–29.5) | |
| Pills and insulin | 14.0 (12.6–15.4) | 11.6 (10.1–13.0) | 22.6 (18.8–26.4) | |
| Neither | 16.1 (14.3–17.9) | 17.7 (15.7–19.7) | 10.5 (6.8–14.3) | |
| HF (yes %) | 10.4 (9.1–11.7) | 8.6 (7.2–10.0) | 17.1 (13.6–20.6) | 0.0003 |
| CHD (yes %) | 12.0 (10.6–13.4) | 10.7 (9.2–12.3) | 16.6 (12.8–20.4) | 0.0002 |
| Heart attack | 12.3 (10.7–13.8) | 11.3 (9.7–12.9) | 15.7 (12.0–19.4) | 0.0029 |
| Stroke (yes %) | 10.3 (9.0– 11.7) | 9.0 (7.7–10.3) | 15.2 (11.5–19.0) | <0.0001 |
| Liver condition (yes %) | 9.1 (7.7–10.4) | 7.8 (6.4–9.3) | 13.5 (1.6–10.3) | 0.0006 |
| Renal failure (yes %) | 9.5 (8.3–10.8) | 6.8 (5.7–7.9) | 19.4 (15.8–23.0) | <0.0001 |
|
| 0.0007 | |||
| None (0 to 4) | 66.5 (64.3–68.7) | 68.5 (66.0–70.9) | 59.5 (55.1–64.0) | |
| Mild and moderate (5 to 14) | 28.1 (25.9–30.2) | 26.8 (24.4–29.1) | 32.8 (28.6–37.0) | |
| Severe (≥15) | 5.4 (4.5–6.3) | 4.8 (3.8–5.8) | 7.7 (5.2–10.1) | |
|
| ||||
|
| 0.0145 | |||
| Being drinking | 11.0 (9.6–12.4) | 10.5 (9.1–11.9) | 12.6 (9.3–15.9) | |
| Seldom | 46.4 (43.3–49.5) | 47.9 (44.6–51.1) | 41.0 (35.8–46.3) | |
| Former | 6.7 (5.5–8.0) | 6.1 (4.9–7.3) | 8.8 (5.7–11.9) | |
| Never | 35.7 (33.0–38.5) | 35.2 (32.2–38.2) | 37.5 (32.8–42.2) | |
| Moderate recreational activities | 34.2 (32.0–36.4) | 35.4 (32.9–38.0) | 29.8 (25.8–33.8) | 0.0205 |
|
| 0.0054 | |||
| <6h | 16.2 (14.4–18.0) | 15.2 (13.4–16.9) | 20.0 (15.7–24.4) | |
| 6 to 8h | 65.0 (62.4–67.6) | 67.0 (64.5–69.5) | 57.8 (52.0–63.6) | |
| >8h | 18.8 (15.9–21.6) | 17.8 (15.2–20.4) | 22.2 (16.3–28.1) | |
Abbreviations: NHANES, National Health and Nutrition Examination Surveys; CI, confidence interval; DR, diabetic retinopathy; GED, General Educational Development; AA, Associate of Arts; PIR, Ratio of family income to poverty level; SBP, systolic blood pressure; HbA1c, glycosylated hemoglobin; ACR, urinary microalbumin/creatinine ratio; it was computed as albumin in milligrams per liter divided by creatinine in grams per liter; HF, Heart failure; CHD, coronary heart disease.
This is a comparison between non–DR and DR adults having diabetes.
The unweighted number of cases.
All cases are weighted to be nationally representative.
PIR was calculated by dividing the family income by the poverty guidelines specific to the survey year. The respondent only reported income as < $20,000 or ≥ $20,000, and the value was not computed.
Number of private insurances covered by Medigap and single service plan.
Doctors or health professionals diagnosed them.
Sports, fitness, and recreational activities exclude the work and transport activities for at least 10 min continuously in a typical week.
Figure 2Multivariable forest plot of the association between factors and DR (Model 1). Model 1 was performed by adjusting sociodemographic variables. DR, diabetic retinopathy; OR, odds ratios; CI, confidence interval; GED, General Educational Development; AA, Associate of Arts; PIR, Ratio of family income to the poverty level, PIR was calculated by dividing family income by the poverty guidelines specific to the survey year, and the respondent only reported income as < $20,000 or ≥ $20,000, the value was not computed.
Figure 3Multivariate forest plot of the association between factors and DR (Model 4). Model 4 was performed by adjusting all covariables, including sociodemographic variables, diabetic-related clinical variables, diabetic comorbidities, behavioral variables, and sociodemographic variables. DR, diabetic retinopathy; OR, odds ratios; CI, confidence interval; GED, General Educational Development; AA, Associate of Arts; PIR, Ratio of family income to the poverty level. PIR was calculated by dividing the family income by the poverty guidelines specific to the survey year; the respondent only reported income as < $20,000 or ≥ $20,000, and the value was not computed; SBP, systolic blood pressure; RBC, red blood cell; HbA1c, glycosylated hemoglobin; HF, heart failure; CHD, coronary heart disease.
Associations of depressive symptom severity and DR.
|
|
| ||||
|---|---|---|---|---|---|
|
|
|
|
|
| |
| Proportion (%) | 59.5 | 32.8 | 7.7 | ||
| Model 1 | Ref | 1.440 (1.149 to 1.804) | 0.0017 | 1.704 (1.100 to 2.640) | 0.0173 |
| Model 2 | Ref | 1.504 (1.184 to 1.910) | 0.0009 | 1.576 (1.006 to 2.470) | 0.0473 |
| Model 3 | Ref | 1.437 (1.118 to 1.846) | 0.0048 | 1.404 (0.881 to 2.238) | 0.1527 |
| Model 4 | Ref | 1.377 (1.062 to 1.785) | 0.0160 | 1.337 (0.825 to 2.166) | 0.2377 |
Prevalence of depressive symptom severity in DR.
Model 1 adjusted for sociodemographic variables (gender, education, income, PIR, and private insurance).
Model 2 adjusted for sociodemographic and diabetic-related clinical variables (systolic blood pressure, lymphocyte count, RBC, HbA1c%, fasting glucose, relatives having diabetes, duration of diabetes, frequency of self-monitoring of blood, the last time had pupils dilated for exams, and treatment).
Model 3 adjusted for sociodemographic, diabetic-related clinical variables, and diabetic comorbidities and complications (the total number of comorbidities, HF, CHD, MI, stroke, liver condition, and renal failure).
Model 4 adjusted for all covariables, including sociodemographic variables, diabetic-related clinical variables, comorbidities and complications, and behavioral variables (drinking, moderate recreational activities, and sleep hours).